Speciality Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Education Dialogues
    • Business Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Speciality Medical Dialogues
    • Editorial
    • News
        • Anesthesiology
        • Cancer
        • Cardiac Sciences
        • Critical Care
        • Dentistry
        • Dermatology
        • Diabetes and Endo
        • Diagnostics
        • ENT
        • Featured Research
        • Gastroenterology
        • Geriatrics
        • Medicine
        • Nephrology
        • Neurosciences
        • Nursing
        • Obs and Gynae
        • Ophthalmology
        • Orthopaedics
        • Paediatrics
        • Parmedics
        • Pharmacy
        • Psychiatry
        • Pulmonology
        • Radiology
        • Surgery
        • Urology
    • Practice Guidelines
        • Anesthesiology Guidelines
        • Cancer Guidelines
        • Cardiac Sciences Guidelines
        • Critical Care Guidelines
        • Dentistry Guidelines
        • Dermatology Guidelines
        • Diabetes and Endo Guidelines
        • Diagnostics Guidelines
        • ENT Guidelines
        • Featured Practice Guidelines
        • Gastroenterology Guidelines
        • Geriatrics Guidelines
        • Medicine Guidelines
        • Nephrology Guidelines
        • Neurosciences Guidelines
        • Obs and Gynae Guidelines
        • Ophthalmology Guidelines
        • Orthopaedics Guidelines
        • Paediatrics Guidelines
        • Psychiatry Guidelines
        • Pulmonology Guidelines
        • Radiology Guidelines
        • Surgery Guidelines
        • Urology Guidelines
    LoginRegister
    Speciality Medical Dialogues
    LoginRegister
    • Home
    • Editorial
    • News
      • Anesthesiology
      • Cancer
      • Cardiac Sciences
      • Critical Care
      • Dentistry
      • Dermatology
      • Diabetes and Endo
      • Diagnostics
      • ENT
      • Featured Research
      • Gastroenterology
      • Geriatrics
      • Medicine
      • Nephrology
      • Neurosciences
      • Nursing
      • Obs and Gynae
      • Ophthalmology
      • Orthopaedics
      • Paediatrics
      • Parmedics
      • Pharmacy
      • Psychiatry
      • Pulmonology
      • Radiology
      • Surgery
      • Urology
    • Practice Guidelines
      • Anesthesiology Guidelines
      • Cancer Guidelines
      • Cardiac Sciences Guidelines
      • Critical Care Guidelines
      • Dentistry Guidelines
      • Dermatology Guidelines
      • Diabetes and Endo Guidelines
      • Diagnostics Guidelines
      • ENT Guidelines
      • Featured Practice Guidelines
      • Gastroenterology Guidelines
      • Geriatrics Guidelines
      • Medicine Guidelines
      • Nephrology Guidelines
      • Neurosciences Guidelines
      • Obs and Gynae Guidelines
      • Ophthalmology Guidelines
      • Orthopaedics Guidelines
      • Paediatrics Guidelines
      • Psychiatry Guidelines
      • Pulmonology Guidelines
      • Radiology Guidelines
      • Surgery Guidelines
      • Urology Guidelines
    • Home
    • Practice Guidelines
    • Featured Practice Guidelines
    • AGI's...

    AGI's latest Guidelines for Management of Acute Pancreatitis

    Written by Dr. Kamal Kant Kohli Kohli Published On 2018-04-18T19:02:31+05:30  |  Updated On 18 April 2018 7:02 PM IST
    AGIs latest Guidelines for Management of Acute Pancreatitis

    AP (acute pancreatitis) is an inflammatory condition of the pancreas that can cause local injury, systemic inflammatory response syndrome, and organ failure. Worldwide, AP (acute pancreatitis) is a common gastrointestinal condition that is associated with substantial suffering, morbidity, and cost to the healthcare system.


    American Gastroenterological Association has released its latest Clinical Guidelines for the Initial Management of Acute Pancreatitis.The early phase of AP has been defined as first 2 weeks after disease onset, and the late phase can last weeks to months thereafter.The Guidelines have been published in Gastroenterology.


    Key Recommendations :

    • AGA suggests against the use of hydroxymethyl starch (HES) fluids in patients with AP.

    • In patients with predicted severe AP and necrotizing AP, the AGA suggests against the use of prophylactic antibiotics.

    • In patients with acute biliary pancreatitis and no cholangitis, the AGA suggests against the routine use of urgent ERCP.

    • In patients with AP, the AGA recommends early (within 24 hr) oral feeding as tolerated, rather than keeping the patient nil per os.

    • In patients with AP and inability to feed orally, the AGA recommends enteral rather than parenteral nutrition.

    • In patients with predicted severe or necrotizing pancreatitis requiring enteral tube feeding, the AGA suggests either nasogastric or nasojejunal route.

    • In patients with acute biliary pancreatitis, the AGA recommends cholecystectomy during the initial admission rather than after discharge.

    • In patients with acute alcoholic pancreatitis, the AGA recommends brief alcohol intervention during admission.Strong recommendation, moderate quality evidence.


    There are several knowledge gaps in the initial management of AP that have been identified for which RCTs are warranted, as is highlighted in the technical review that accompanies this guideline.




    1. More evidence is needed to deterimine the optimal fluid therapy practice in AP, and to better quantify the benefits and harms of goal-directed therapy vs other approaches.

    2. Current evidence does not support a clear benefit of Ringer’s lactate solution compared to normal saline for important outcomes, such as organ failure, necrosis, or mortality.

    3. High-quality multicenter RCTs are required to determine whether prophylactic antibiotics have a role in specific groups of patients with predicted severe AP and necrotizing pancreatitis.

    4. The appropriate timing of ERCP in patients with predicted severe biliary pancreatitis with persistent biliary obstruction also needs to be clarified in future studies.


    The experts feel that future research should focus on the impact of alcohol and tobacco cessation interventions on endpoints, such as recurrent AP, progression to chronic pancreatitis and pancreatic cancer, quality of life, health care utilization, and mortality.


    For further reference log on to:

    DOI: https://doi.org/10.1053/j.gastro.2018.01.032
    cholangitisCholecystectomyfluid therapyGastroenterologygastrointestinalhydroxymethyljournal Gastroenterologynecrosispancreatic cancerParenteral nutritionProphylactic antibiotics
    Source : With inputs Journal Gastroenterology

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Dr. Kamal Kant Kohli Kohli
    Dr. Kamal Kant Kohli Kohli
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 12 Oct 2022 7:06 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok